4 ms·
That's a pretty strong claim. Do you have a source for that?
by Scandiravian 3y ago
That's a pretty strong claim. Do you have a source for that?
- pfdietz 3y agoSince the price of Ozempic in France is 1/10th the price in the US, you either admit France is not paying their share of the development costs, or you think the US price is way excessive even taking development into account.
- Scandiravian 3y agoThe price is not set to solely recoup the development cost. It's set to produce a profit. Secondly, Novo has probably made sales for around 80-100 billion dollars for Wegovy and Ozempic at this point. Given that 20%-25% of that are from sales in the EU, that's somewhere along the lines of 16-25 billion dollars, more than enough to recapture the cost of development already The price in the US is higher because the US has created a system, that prioritise corporate interests above that of the individual. The price of these drugs are low in Europe because the population fought for affordable healthcare (among other things) I definitely think that the price of healthcare in the US is excessive, not just the price of Ozempic. The reason for that is not that other countries are free-riding, but because the US voters continuously have voted for politicians that put corporate interests above those of their constituents Healthcare providers in the US are free to band together to improve their bargaining power when purchasing drugs, just like most countries in the EU does That'll however require that the US starts electing officials who actually work in the interest of the public